{"database": "lobbying", "table": "lobbying_activities", "rows": [[1657724, "241ff137-0be4-4dd6-bf3b-0f6c408dd87a", "Q1", "RED+BLUE STRATEGIES", 400693064, "EXPRESS SCRIPTS INC.", 2015, "first_quarter", "MMM", "Policies and regulations focused on Medicare Part C and Part D with a focus on coverage of prescription medications, formulary design and access to specialty drugs.\n\nPolicies focused on ensuring affordable access to Biosimilar medications for Medicare and Medicaid beneficiaries as well as those in the private market.\n\nPolicies focused on ending prescription drug abuse in the Medicare Part D program. \n\nIssues related to the Medicare Call letter related to preferred pharmacy networks in Medicare Part D. \n\nACA- related regulations impacting Federal and State Based Marketplaces'' coverage of prescription medications.\n\nIssues related to cost of and access to specialty medications and their impact on consumers and purchasers.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2015-04-09T12:05:04.293000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1657724"], "units": {}, "query_ms": 0.45995297841727734, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}